
A special issue of Acta Oncologica stemming from the Nordic Precision Cancer Medicine Symposium 2025 is now available (download pdf below).
Read, among other things, about data-sharing procedures in the Cancer Mission project PRIME-ROSE; a conceptual health economic modelling framework for assessing the cost-effectiveness of molecularly targeted treatment regimens in oncology; clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from IMPRESS-Norway; targeted treatment of lung cancer in Iceland during the period 2010–2023; cross-border data standardization in PRIME-ROSE using the OMOP model; and the national DRUP-like study in Sweden: FOCU.SE.
The Nordic Precision Cancer Medicine Symposium will return to Oslo in autumn 2027 – more information will be available coming soon!
